Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Vimentin Antikörper (FITC)

VIM Reaktivität: Human, Rind (Kuh), Huhn, Affe, Hund, Amphibien WB, IF, FACS, IHC (p), IHC (fro), EIA Wirt: Maus Monoclonal VIM 3B4 FITC
Produktnummer ABIN112308
  • Target Alle Vimentin (VIM) Antikörper anzeigen
    Vimentin (VIM)
    Reaktivität
    • 325
    • 126
    • 125
    • 60
    • 58
    • 43
    • 42
    • 36
    • 30
    • 22
    • 20
    • 14
    • 13
    • 8
    • 7
    • 6
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Rind (Kuh), Huhn, Affe, Hund, Amphibien
    Wirt
    • 187
    • 123
    • 9
    • 6
    • 4
    • 4
    • 2
    Maus
    Klonalität
    • 198
    • 136
    Monoklonal
    Konjugat
    • 193
    • 19
    • 13
    • 12
    • 10
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Dieser Vimentin Antikörper ist konjugiert mit FITC
    Applikation
    • 274
    • 126
    • 99
    • 95
    • 94
    • 58
    • 46
    • 40
    • 39
    • 27
    • 23
    • 18
    • 8
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)
    Spezifität
    This antibody is highly specific for the intermediate filament protein Vimentin. Polypeptide reacting: Mr 57 000 intermediate filament protein (Vimentin) of mesenchymal cells. The binding region of monoclonal antibody VIM3B4 has been characterized by Bohn et al. (1992). According to these authors, the epitope has been localized on the alpha-helical part of Vimentin (rod domain coil 2). Due to an aa substitution at position of aa 353 in murine Vimentin (that could explain for the weak cross-reaction of the antibody with murine Vimentin) they were able to narrow down the binding region around position 353. These findings were confirmed by truncation mutagenesis experiments using Human Vimentin (Rogers et al., 1995). Clone VIM 3B4 has turned out to be the most avid mab to Vimentin. Tumors Specifically Detected: Sarcoma (including myosarcoma), lymphoma, melanoma. Tested Reactivities on Cultured Cell Lines: RD cells, glioma cells, fibroblasts (SV-80), MDCK.
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human, Monkey, Bovine, Dog, Chicken, Amphibian (e.g. Xenopus leavis). Weaker Murine cross-reaction.
    Aufreinigung
    Affinity Chromatography on Protein A
    Immunogen
    Vimentin (purified from Bovine lens)
    Klon
    VIM 3B4
    Isotyp
    IgG2a
    Top Product
    Discover our top product VIM Primärantikörper
  • Applikationshinweise
    ELISA. Immunoblotting. Flow Cytometry. Immunofluorescence Microscopy (5-10 μg/mL recommended)Immunohistochemistry (dilute at least 1/10 with PBS, pH 7.4). Suitable for Frozen and Paraffin-Embedded tissue and Cytological Material. Withparaffin-embedded sections, protease pretreatment is required prior to antibodyapplication. Incubation Time: 1 h at RT, extended with paraffin.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    Vimentin (VIM)
    Andere Bezeichnung
    Vimentin (VIM Produkte)
    Synonyme
    CTRCT30 antikoerper, cb28 antikoerper, vime antikoerper, vim antikoerper, vim1 antikoerper, vim2 antikoerper, VIM antikoerper, Vimentin antikoerper, vim4 antikoerper, vimentin antikoerper, vimentin L homeolog antikoerper, vimentin S homeolog antikoerper, VIM antikoerper, Vim antikoerper, vim antikoerper, vim.L antikoerper, vim.S antikoerper
    Hintergrund
    Vimentin is an intermediate filament protein which is present in all cells of mesenchymal origin. Vimentin is the major subunit protein of the intermediate filaments of mesenchymal cells. It is believed to be involved with the intracellular transport of proteins between the nucleus and plasma membrane. Vimentin has been implicated to be involved in the rate of steroid synthesis via its role as a storage network for steroidogenic cholesterol containing lipid droplets. Vimentin phosphorylation by a protein kinase causes the breakdown of intermediate filaments and activation of an ATP and myosin light chain dependent contractile event. This results in cytoskeletal changes that facilitate the interaction of the lipid droplets within mitochondria, and subsequent transport of cholesterol to the organelles leading to an increase in steroid synthesis. Immunohistochemical staining for Vimentin is characteristic of sarcomas (of neural, muscle and fibroblast origin) compared to carcinomas which are generally negative. Melanomas, lymphomas and vascular tumors may all stain for Vimentin. Vimentin antibodies are thus of value in the differential diagnosis of undifferentiated neoplasms and malignant tumors. They are generally used with a panel of other antibodies including those recognizing cytokeratins, lymphoid markers, S100, desmin and neurofilaments.Synonyms: VIM
    Gen-ID
    7431
    NCBI Accession
    NP_003371
    UniProt
    P08670
    Pathways
    Caspase Kaskade in der Apoptose
Sie sind hier:
Kundenservice